Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Rosuvastatin

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Rosuvastatin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 623Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Egis' medicines won the Innovation Grand Prize
    Egis' medicines won the Innovation Grand Prize

    26 Mar 2024

    // PRESS RELEASE

    https://int.egis.health/a/egis-medicines-won-the-innovation-grand-prize

    PRESS RELEASE
    26 Mar 2024
    Share Share
    Enforcement Report - Week of April 12, 2023
    Enforcement Report - Week of April 12, 2023

    12 Apr 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2023-46659.pdf

    FDA
    12 Apr 2023
    Share Share
    Enforcement Report - Week of March 8, 2023
    Enforcement Report - Week of March 8, 2023

    08 Mar 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf

    FDA
    08 Mar 2023
    Share Share
    JB Pharma acquires cardiac brand from Glenmark for Rs 314 crore
    JB Pharma acquires cardiac brand from Glenmark for Rs 314 crore

    15 Dec 2022

    // Viswanath Pilla ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/jb-pharma-acquires-cardiac-brand-from-glenmark-for-rs-314-crore/articleshow/96234363.cms

    Viswanath Pilla ECONOMIC TIMES
    15 Dec 2022
    Share Share
    FDA Issues Untitled Letter to Althera for Statements Relating to ROSZET
    FDA Issues Untitled Letter to Althera for Statements Relating to ROSZET

    24 Jun 2022

    // Dominick & Arushi LEXBLOG

    https://www.lexblog.com/2022/06/23/fda-issues-untitled-letter-to-althera-pharmaceuticals-statements-relating-to-roszet/

    Dominick & Arushi LEXBLOG
    24 Jun 2022
    Share Share
    FDA slams Althera for misleading ad with dearth of safety info & dubious stats
    FDA slams Althera for misleading ad with dearth of safety info & dubious stats

    08 Jun 2022

    // Z. Brennan ENDPTS

    https://endpts.com/fda-slams-small-pharma-for-misleading-ad-with-a-dearth-of-safety-info-and-dubious-stat-calculations/

    Z. Brennan ENDPTS
    08 Jun 2022
    Share Share